Why a Song?
There are a lot of sounds surrounding type 1 diabetes—from peeling back the wrapper of a new Pod to tapping out the air bubbles in a syringe filled with insulin, and of course, the beep confirmation after you fill a Pod with insulin. “The Pod Drop” transforms the sounds of a Pod change into an upbeat music track that celebrates everyone in the diabetes community who has changed out their devices.
Meet Andrew and Lexie
Andrew Huang is a musician, YouTube creator and author who composes songs out of anything—including the Omnipod 5 Automated Insulin Delivery System. Lexie Peterson, @TheDivabetic, is a T1D advocate, content creator, and Podder® who uses her platform to encourage other people with diabetes to live their best life.
Watch below to see Andrew unveil “The Pod Drop” for the first time to Lexie.
Share to Benefit Diabetes
For every social post that includes “The Pod Drop,” Omnipod will donate $1 to Breakthrough T1D (formerly JDRF) up to $5,000 to support breakthrough research that advances treatments for those living with type 1 diabetes.
Don’t forget to use #ThePodDrop.
Download. Create. Share.
Can’t get enough of “The Pod Drop (Pod Change Theme Song)?” We get it. Download it below.
Want to create your own track using samples of “The Pod Drop?” We can’t wait to hear it!
Add it to your next Pod change or day in the life social post by searching “The Pod Drop (Pod Change Theme Song)” when you’re posting—just like you would for any song.
Don’t forget to tag @Omnipod and include #ThePodDrop.
FAQs
How do I add “The Pod Drop” to my next Instagram Story?
Can I share the song and beats on my social feed?
Is the song really only made from the sounds of a Pod change?
Risk Statement
The Omnipod 5 Automated Insulin Delivery System is indicated for use by individuals with type 1 diabetes mellitus in persons 2 years of age and older and type 2 diabetes mellitus in persons 18 years of age and older. The Omnipod 5 System is intended for single patient, home use and requires a prescription. The Omnipod 5 System is compatible with the following U-100 insulins: NovoLog®, Humalog®, and Admelog®.
The Omnipod 5 ACE Pump (Pod) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Omnipod 5 ACE Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. SmartAdjust™ technology is intended for use with compatible integrated continuous glucose monitors (iCGM) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and pause delivery of insulin based on current and predicted glucose values.
The Omnipod 5 SmartBolus Calculator is intended to calculate a suggested bolus dose based on user-entered carbohydrates, most recent sensor glucose value (or blood glucose reading if using fingerstick), rate of change of the sensor glucose (if applicable), insulin on board (IOB), and programmable correction factor, insulin to carbohydrate ratio, and target glucose value.
WARNING: SmartAdjust technology should NOT be used by anyone under the age of 2 years old. SmartAdjust technology should also NOT be used in people who require less than 5 units of insulin per day as the safety of the technology has not been evaluated in this population.
The Omnipod 5 System is NOT recommended for people who are unable to monitor glucose as recommended by their healthcare provider, are unable to maintain contact with their healthcare provider, are unable to use the Omnipod 5 System according to instructions, are taking hydroxyurea as it could lead to falsely elevated CGM values and result in over-delivery of insulin that can lead to severe hypoglycemia, and do NOT have adequate hearing and/or vision to allow recognition of all functions of the Omnipod 5 System, including alerts, alarms, and reminders. Device components including the Pod, CGM transmitter, and CGM sensor must be removed before Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or diathermy treatment. In addition, the Controller and smartphone should be placed outside of the procedure room. Exposure to MRI, CT, or diathermy treatment can damage the components. Visit www.omnipod.com/safety for additional important safety information.
WARNING: DO NOT start to use the Omnipod 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.
The Omnipod DASH® Insulin Management System is intended for subcutaneous delivery of insulin at set and variable rates for the management of diabetes mellitus in persons requiring insulin. Additionally, the Omnipod DASH® System is interoperable with a compatible blood glucose meter to receive and display blood glucose measurements. The Omnipod DASH® System has been tested and found to be safe for use with the following U-100 insulin: NovoLog®, Humalog®, Apidra®, Fiasp®, Lyumjev®, or Admelog®. Refer to the Omnipod DASH® Insulin Management System User Guide at omnipod.com for complete safety information including indications, contraindications, warnings, cautions, and instructions.